Markus Haapala

Dr. Markus Haapala

Drug Research Program, Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2007 in Analytical Chemistry
Verified
Journal Article
Closed access
MHMarkus Haapala
Markus Haapala
JPJaroslav Pól
Jaroslav Pól
VSVille Saarela
Ville Saarela
VAVille Arvola
Ville Arvola
TKTapio Kotiaho
Tapio Kotiaho
RKRisto Kostiainen
Risto Kostiainen

1 June 2020 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
KPKati Johanna Piironen
Kati Johanna Piironen
MHMarkus Haapala
Markus Haapala
VTVirpi Talman
Virpi Talman
PJPäivi Järvinen
Päivi Järvinen
TSTiina Sikanen
Tiina Sikanen
Three-dimensional (3D) printing has recently emerged as a cost-effective alternative for the rapid prototyping of microfluidic devices. The feature resolution of 3D printing is particularly well suited for the manufacturing of continuous flow cell culture platforms. Poor cell adhesion or material-induced cell death may, however, limit the introduction of new materials to microfluidic cell culture. In this work, we characterized four commercially available materials commonly used in stereolithography-based 3D printing with respect to long-term (2-month) cell survival on native 3D printed surfaces. Cell proliferation rate, along with material-induced effects on apoptosis and cell survival, were examined in mouse embryonic fibroblasts. Additionally, the feasibility of Dental SG (material with the most favored properties) for culturing of human hepatocytes and human-induced pluripotent stem cells was evaluated. The strength of cell adhesion to Dental SG was further examined over a shear force gradient of 1-89 dyne/cm2 by using a custom-designed microfluidic shear force assay incorporating a 3D printed, tilted and tapered microchannel sealed with a polydimethylsiloxane lid. According to our results, autoclavation of the devices prior to cell seeding played the most important role in facilitating long-term cell survival on the native 3D printed surfaces with the shear force threshold in the range of 3-8 dyne/cm2.

26 March 2008 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
TKTiina J. Kauppila
Tiina J. Kauppila
VAVille Arvola
Ville Arvola
MHMarkus Haapala
Markus Haapala
JPJaroslav Pól
Jaroslav Pól
LALaura Aalberg
Laura Aalberg
RKRisto Kostiainen
Risto Kostiainen

6 September 2008 in Analytical Chemistry
Verified
Journal Article
Closed access
LLLaura Luosujärvi
Laura Luosujärvi
VAVille Arvola
Ville Arvola
MHMarkus Haapala
Markus Haapala
JPJaroslav Pól
Jaroslav Pól
VSVille Saarela
Ville Saarela
TKTiina J. Kauppila
Tiina J. Kauppila

4 April 2007 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
VSVille Saarela
Ville Saarela
MHMarkus Haapala
Markus Haapala
RKRisto Kostiainen
Risto Kostiainen
TKTapio Kotiaho
Tapio Kotiaho
SFSami Franssila
Sami Franssila
A microfluidic nebulizer chip for mass spectrometry is presented. It is an all-glass device which consists of fusion bonded Pyrex wafers with embedded flow channels and a nozzle at the chip edge. A platinum heater is located on the wafer backside. Fabrication of the chip is detailed, especially glass deep etching, wafer bonding, and metal patterning. Various process combinations of bonding and metallization have been considered (anodic bonding vs. fusion bonding; heater inside/outside channel; metallization before/after bonding; platinum lift-off vs. etching). The chip vaporizes the liquid sample (0.1–10 μL min−1) and mixes it with a nebulizer gas (ca. 100 sccm N2). Operating temperatures can go up to 500 °C ensuring efficient vaporization. Thermal insulation of the glass ensures low temperatures at the far end of the chip, enabling easy interconnections.

6 April 2011 in Forensic Science International
Verified
Journal Article
Closed access
TKTiina J. Kauppila
Tiina J. Kauppila
AFAnu Flink
Anu Flink
MHMarkus Haapala
Markus Haapala
ULUlla-Maija Laakkonen
Ulla-Maija Laakkonen
LALaura Aalberg
Laura Aalberg
RKRisto Kostiainen
Risto Kostiainen